All the news articles and press releases in one place.

Date / Time Source Ticker Company Sector Market Cap Announcement
12Jun24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
05Jun24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Acquisition of Fusion completed
03Jun24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
03Jun24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Tagrisso plus chemo recommended for approval in EU
28May24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Dato-DXd improved OS in nonsquamous lung cancer
21May24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca to deliver $80bn revenue by 2030
20May24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca to manufacture ADCs in Singapore
16May24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - SUPERNOVA Trial Met COVID-19 prevention endpoint
15May24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
07May24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca completes Cellectis equity investment
02May24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Calquence combination improved PFS in 1L MCL
01May24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
29Apr24 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Truqap recommended for EU breast cancer approval
29Apr24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Enhertu improved PFS in HER2-low and ultralow
29Apr24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Enhertu improved PFS in HER2-low and ultralow
25Apr24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - 1st Quarter Results
11Apr24 17:30 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Result of AGM
11Apr24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca increases 2024 dividend by 7%
08Apr24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Enhertu approved in US for HER2+ solid tumours
05Apr24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Imfinzi improved OS & PFS in limited-stage SCLC
02Apr24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
02Apr24 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Voydeya approved in US
02Apr24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - FDA accepts Dato-DXd BLA for breast cancer
25Mar24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Ultomiris approved in the US for NMOSD
19Mar24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca to acquire Fusion
14Mar24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca to acquire Amolyt
12Mar24 11:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
07Mar24 11:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Notice of AGM
06Mar24 15:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
06Mar24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
04Mar24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - EMA validates Dato-DXd MAAs for NSQ NSCLC and BC
01Mar24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
26Feb24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Voydeya recommended for EU approval
22Feb24 13:15 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Acquisition of Gracell completed
22Feb24 11:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
22Feb24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca prices a $5bn bond offering
21Feb24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Filing of Form 20-F with SEC
20Feb24 11:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Annual Financial Report
19Feb24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca completes acquisition of Icosavax
19Feb24 07:10 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Tagrisso plus chemo approved in US for lung cancer
19Feb24 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - FDA accepts Dato-DXd BLA for nonsquamous NSCLC
19Feb24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Tagrisso improved PFS in Stage III lung cancer
08Feb24 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Final Results
01Feb24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
02Jan24 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
27Dec23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca acquires Gracell
22Dec23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Wainua (eplontersen) granted first US FDA approval
14Dec23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
12Dec23 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca to acquire Icosavax
01Dec23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
01Dec23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Discontinuation of two CRYSTALIZE evidence trials
23Nov23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
17Nov23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Truqap approved in US for HR+ breast cancer
14Nov23 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Update on PACIFIC-2 Phase III trial for Imfinzi
09Nov23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director Declaration
09Nov23 07:10 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Imfinzi combination improves PFS in liver cancer
09Nov23 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Agreement with Eccogene for clinical stage GLP-1RA
09Nov23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - 9M and Q3 2023 results
01Nov23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
01Nov23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca cell & gene therapy deal w/ Cellectis
03Oct23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca settles Nexium liability litigations
02Oct23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
22Sep23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Dato-DXd improved PFS in breast cancer
20Sep23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Alexion completes Pfizer gene therapy agreement
15Sep23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Enhertu recommended in EU for HER2-mutant NSCLC
11Sep23 16:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Fasenra Phase III EGPA trial met primary endpoint
06Sep23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Update on US review of Ultomiris for NMOSD
01Sep23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
01Aug23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
28Jul23 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Alexion enters gene therapy agreement with Pfizer
28Jul23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Half-year Report
17Jul23 18:10 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Beyfortus approved in US for infant RSV prevention
03Jul23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
03Jul23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Dato-DXd significantly improved PFS in lung cancer
09Jun23 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - nirsevimab recommended for infant RSV protection
09Jun23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca agreement with Quell Therapeutics
02Jun23 17:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Imfinzi improved pCR in gastric and GEJ cancers
01Jun23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
01Jun23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Lynparza approved in US for BRCAm prostate cancer
26May23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Imfinzi + Lynparza prolonged PFS in endometrial ca
22May23 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Directorate Change
17May23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Tagrisso plus chemo improved PFS in lung cancer
09May23 11:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
09May23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Farxiga extended in the US for heart failure
02May23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
02May23 10:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
02May23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - ODAC vote on Lynparza combo in prostate cancer
27Apr23 17:30 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Result of AGM
27Apr23 07:05 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Board Committee Changes
27Apr23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - 1st Quarter Results
26Apr23 16:45 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director Declaration
11Apr23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Update to arrangements with Sobi and Sanofi
05Apr23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Lynparza + Imfinzi met endpoint in ovarian cancer
03Apr23 15:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Total Voting Rights
03Apr23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Ultomiris recommended for NMOSD EU approval
30Mar23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - AstraZeneca completes KYM agreement for CMG901
27Mar23 11:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
22Mar23 11:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Notice of AGM
09Mar23 07:00 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Imfinzi improved EFS in resectable lung cancer
08Mar23 11:01 RNS AZN:LON AstraZeneca PLC Health £193,332m AstraZeneca PLC - Director/PDMR Shareholding
Date / Time Source Company % Chg
12Jun24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
05Jun24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Acquisition of Fusion completed
03Jun24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
03Jun24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso plus chemo recommended for approval in EU
28May24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Dato-DXd improved OS in nonsquamous lung cancer
21May24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to deliver $80bn revenue by 2030
20May24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to manufacture ADCs in Singapore
16May24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - SUPERNOVA Trial Met COVID-19 prevention endpoint
15May24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
07May24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca completes Cellectis equity investment
02May24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Calquence combination improved PFS in 1L MCL
01May24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
29Apr24 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Truqap recommended for EU breast cancer approval
29Apr24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu improved PFS in HER2-low and ultralow
29Apr24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu improved PFS in HER2-low and ultralow
25Apr24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - 1st Quarter Results
11Apr24 17:30 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Result of AGM
11Apr24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca increases 2024 dividend by 7%
08Apr24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu approved in US for HER2+ solid tumours
05Apr24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi improved OS & PFS in limited-stage SCLC
02Apr24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
02Apr24 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Voydeya approved in US
02Apr24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - FDA accepts Dato-DXd BLA for breast cancer
25Mar24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Ultomiris approved in the US for NMOSD
19Mar24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to acquire Fusion
14Mar24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to acquire Amolyt
12Mar24 11:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
07Mar24 11:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Notice of AGM
06Mar24 15:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
06Mar24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
04Mar24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - EMA validates Dato-DXd MAAs for NSQ NSCLC and BC
01Mar24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
26Feb24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Voydeya recommended for EU approval
22Feb24 13:15 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Acquisition of Gracell completed
22Feb24 11:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
22Feb24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca prices a $5bn bond offering
21Feb24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Filing of Form 20-F with SEC
20Feb24 11:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Annual Financial Report
19Feb24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca completes acquisition of Icosavax
19Feb24 07:10 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso plus chemo approved in US for lung cancer
19Feb24 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - FDA accepts Dato-DXd BLA for nonsquamous NSCLC
19Feb24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso improved PFS in Stage III lung cancer
08Feb24 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Final Results
01Feb24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
02Jan24 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
27Dec23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca acquires Gracell
22Dec23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Wainua (eplontersen) granted first US FDA approval
14Dec23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
12Dec23 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to acquire Icosavax
01Dec23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Dec23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Discontinuation of two CRYSTALIZE evidence trials
23Nov23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
17Nov23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Truqap approved in US for HR+ breast cancer
14Nov23 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Update on PACIFIC-2 Phase III trial for Imfinzi
09Nov23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director Declaration
09Nov23 07:10 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi combination improves PFS in liver cancer
09Nov23 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Agreement with Eccogene for clinical stage GLP-1RA
09Nov23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - 9M and Q3 2023 results
01Nov23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Nov23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca cell & gene therapy deal w/ Cellectis
03Oct23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca settles Nexium liability litigations
02Oct23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
22Sep23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Dato-DXd improved PFS in breast cancer
20Sep23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Alexion completes Pfizer gene therapy agreement
15Sep23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu recommended in EU for HER2-mutant NSCLC
11Sep23 16:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Fasenra Phase III EGPA trial met primary endpoint
06Sep23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Update on US review of Ultomiris for NMOSD
01Sep23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Aug23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
28Jul23 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Alexion enters gene therapy agreement with Pfizer
28Jul23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Half-year Report
17Jul23 18:10 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Beyfortus approved in US for infant RSV prevention
03Jul23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
03Jul23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Dato-DXd significantly improved PFS in lung cancer
09Jun23 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - nirsevimab recommended for infant RSV protection
09Jun23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca agreement with Quell Therapeutics
02Jun23 17:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi improved pCR in gastric and GEJ cancers
01Jun23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Jun23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Lynparza approved in US for BRCAm prostate cancer
26May23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi + Lynparza prolonged PFS in endometrial ca
22May23 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Directorate Change
17May23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso plus chemo improved PFS in lung cancer
09May23 11:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
09May23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Farxiga extended in the US for heart failure
02May23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
02May23 10:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
02May23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - ODAC vote on Lynparza combo in prostate cancer
27Apr23 17:30 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Result of AGM
27Apr23 07:05 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Board Committee Changes
27Apr23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - 1st Quarter Results
26Apr23 16:45 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director Declaration
11Apr23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Update to arrangements with Sobi and Sanofi
05Apr23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Lynparza + Imfinzi met endpoint in ovarian cancer
03Apr23 15:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
03Apr23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Ultomiris recommended for NMOSD EU approval
30Mar23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca completes KYM agreement for CMG901
27Mar23 11:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
22Mar23 11:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Notice of AGM
09Mar23 07:00 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi improved EFS in resectable lung cancer
08Mar23 11:01 RNS AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
Date / Time Company % Chg
12Jun24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
05Jun24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Acquisition of Fusion completed
03Jun24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
03Jun24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso plus chemo recommended for approval in EU
28May24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Dato-DXd improved OS in nonsquamous lung cancer
21May24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to deliver $80bn revenue by 2030
20May24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to manufacture ADCs in Singapore
16May24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - SUPERNOVA Trial Met COVID-19 prevention endpoint
15May24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
07May24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca completes Cellectis equity investment
02May24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Calquence combination improved PFS in 1L MCL
01May24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
29Apr24 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Truqap recommended for EU breast cancer approval
29Apr24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu improved PFS in HER2-low and ultralow
29Apr24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu improved PFS in HER2-low and ultralow
25Apr24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - 1st Quarter Results
11Apr24 17:30 AstraZeneca PLC 0.72%
AstraZeneca PLC - Result of AGM
11Apr24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca increases 2024 dividend by 7%
08Apr24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu approved in US for HER2+ solid tumours
05Apr24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi improved OS & PFS in limited-stage SCLC
02Apr24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
02Apr24 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Voydeya approved in US
02Apr24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - FDA accepts Dato-DXd BLA for breast cancer
25Mar24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Ultomiris approved in the US for NMOSD
19Mar24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to acquire Fusion
14Mar24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to acquire Amolyt
12Mar24 11:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
07Mar24 11:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Notice of AGM
06Mar24 15:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
06Mar24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
04Mar24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - EMA validates Dato-DXd MAAs for NSQ NSCLC and BC
01Mar24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
26Feb24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Voydeya recommended for EU approval
22Feb24 13:15 AstraZeneca PLC 0.72%
AstraZeneca PLC - Acquisition of Gracell completed
22Feb24 11:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
22Feb24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca prices a $5bn bond offering
21Feb24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Filing of Form 20-F with SEC
20Feb24 11:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Annual Financial Report
19Feb24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca completes acquisition of Icosavax
19Feb24 07:10 AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso plus chemo approved in US for lung cancer
19Feb24 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - FDA accepts Dato-DXd BLA for nonsquamous NSCLC
19Feb24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso improved PFS in Stage III lung cancer
08Feb24 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Final Results
01Feb24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
02Jan24 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
27Dec23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca acquires Gracell
22Dec23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Wainua (eplontersen) granted first US FDA approval
14Dec23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
12Dec23 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca to acquire Icosavax
01Dec23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Dec23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Discontinuation of two CRYSTALIZE evidence trials
23Nov23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
17Nov23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Truqap approved in US for HR+ breast cancer
14Nov23 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Update on PACIFIC-2 Phase III trial for Imfinzi
09Nov23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director Declaration
09Nov23 07:10 AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi combination improves PFS in liver cancer
09Nov23 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Agreement with Eccogene for clinical stage GLP-1RA
09Nov23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - 9M and Q3 2023 results
01Nov23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Nov23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca cell & gene therapy deal w/ Cellectis
03Oct23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca settles Nexium liability litigations
02Oct23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
22Sep23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Dato-DXd improved PFS in breast cancer
20Sep23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Alexion completes Pfizer gene therapy agreement
15Sep23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Enhertu recommended in EU for HER2-mutant NSCLC
11Sep23 16:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Fasenra Phase III EGPA trial met primary endpoint
06Sep23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Update on US review of Ultomiris for NMOSD
01Sep23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Aug23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
28Jul23 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Alexion enters gene therapy agreement with Pfizer
28Jul23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Half-year Report
17Jul23 18:10 AstraZeneca PLC 0.72%
AstraZeneca PLC - Beyfortus approved in US for infant RSV prevention
03Jul23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
03Jul23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Dato-DXd significantly improved PFS in lung cancer
09Jun23 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - nirsevimab recommended for infant RSV protection
09Jun23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca agreement with Quell Therapeutics
02Jun23 17:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi improved pCR in gastric and GEJ cancers
01Jun23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
01Jun23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Lynparza approved in US for BRCAm prostate cancer
26May23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi + Lynparza prolonged PFS in endometrial ca
22May23 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Directorate Change
17May23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Tagrisso plus chemo improved PFS in lung cancer
09May23 11:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
09May23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Farxiga extended in the US for heart failure
02May23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
02May23 10:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
02May23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - ODAC vote on Lynparza combo in prostate cancer
27Apr23 17:30 AstraZeneca PLC 0.72%
AstraZeneca PLC - Result of AGM
27Apr23 07:05 AstraZeneca PLC 0.72%
AstraZeneca PLC - Board Committee Changes
27Apr23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - 1st Quarter Results
26Apr23 16:45 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director Declaration
11Apr23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Update to arrangements with Sobi and Sanofi
05Apr23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Lynparza + Imfinzi met endpoint in ovarian cancer
03Apr23 15:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Total Voting Rights
03Apr23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Ultomiris recommended for NMOSD EU approval
30Mar23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - AstraZeneca completes KYM agreement for CMG901
27Mar23 11:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding
22Mar23 11:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Notice of AGM
09Mar23 07:00 AstraZeneca PLC 0.72%
AstraZeneca PLC - Imfinzi improved EFS in resectable lung cancer
08Mar23 11:01 AstraZeneca PLC 0.72%
AstraZeneca PLC - Director/PDMR Shareholding